GO | Category | Description | Count | % | Log10 (P) | Log10 (q) |
---|---|---|---|---|---|---|
hsa05200 | KEGG Pathway | Pathways in cancer | 57/395 | 14.43 | − 42.91 | − 40.22 |
hsa05206 | KEGG Pathway | MicroRNAs in cancer | 47/299 | 15.72 | − 36.99 | − 34.60 |
hsa04151 | KEGG Pathway | PI3K-Akt signaling pathway | 46/342 | 13.45 | − 33.06 | − 30.84 |
hsa04933 | KEGG Pathway | AGE-RAGE signaling pathway in diabetic complications | 29/99 | 29.29 | − 31.22 | − 29.22 |
hsa04110 | KEGG Pathway | Cell cycle | 25/124 | 20.16 | − 22.51 | − 21.02 |
hsa05202 | KEGG Pathway | Transcriptional misregulation in cancer | 23/180 | 12.78 | − 16.11 | − 14.80 |
hsa05230 | KEGG Pathway | Central carbon metabolism in cancer | 16/65 | 24.62 | − 16.07 | − 14.78 |
hsa04668 | KEGG Pathway | TNF signaling pathway | 18/108 | 16.67 | − 14.80 | − 13.55 |
hsa04060 | KEGG Pathway | Cytokine-cytokine receptor interaction | 25/270 | 9.26 | − 14.14 | − 12.92 |
hsa04066 | KEGG Pathway | HIF-1 signaling pathway | 17/101 | 16.83 | − 14.08 | − 12.88 |
hsa05162 | KEGG Pathway | Measles | 18/134 | 13.43 | − 13.10 | − 11.98 |
hsa05144 | KEGG Pathway | Malaria | 12/49 | 24.49 | − 12.16 | − 11.06 |
hsa05216 | KEGG Pathway | Thyroid cancer | 10/29 | 34.48 | − 11.90 | − 10.86 |
hsa04520 | KEGG Pathway | Adherens junction | 13/72 | 18.06 | − 11.31 | − 10.30 |
hsa04659 | KEGG Pathway | Th17 cell differentiation | 15/107 | 14.02 | − 11.29 | − 10.29 |
hsa04390 | KEGG Pathway | Hippo signaling pathway | 17/154 | 11.04 | − 11.00 | − 10.02 |
hsa04064 | KEGG Pathway | NF-kappa B signaling pathway | 12/95 | 12.63 | − 8.61 | − 7.76 |
hsa04350 | KEGG Pathway | TGF-beta signaling pathway | 11/84 | 13.10 | − 8.11 | − 7.27 |
hsa04670 | KEGG Pathway | Leukocyte transendothelial migration | 12/114 | 10.53 | − 7.70 | − 6.86 |
hsa04360 | KEGG Pathway | Axon guidance | 13/175 | 7.43 | − 6.49 | − 5.73 |